日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

肾移植受者从钙调神经磷酸酶抑制剂转换为贝拉西普治疗后的心血管风险:一项随机临床试验

Bredewold, Obbo W; Chan, Joe; Svensson, My; Bruchfeld, Annette; de Fijter, Johan W; Furuland, Hans; Grinyo, Josep M; Hartmann, Anders; Holdaas, Hallvard; Hellberg, Olof; Jardine, Alan; Mjörnstedt, Lars; Skov, Karin; Smerud, Knut T; Soveri, Inga; Sørensen, Søren S; Zonneveld, Anton-Jan van; Fellström, Bengt

Increased risk of ischaemic heart disease after kidney donation

肾脏捐献后患缺血性心脏病的风险增加

Haugen, Anders J; Hallan, Stein; Langberg, Nina E; Dahle, Dag Olav; Pihlstrøm, Hege; Birkeland, Kåre I; Reisæter, Anna V; Midtvedt, Karsten; Hartmann, Anders; Holdaas, Hallvard; Mjøen, Geir

Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial

血液透析患者血清纤维化标志物、心血管疾病和全因死亡率:AURORA试验

Salib, Madonna; Girerd, Sophie; Girerd, Nicolas; März, Winfried; Scharnagl, Hubert; Massy, Ziad A; Leroy, Céline; Duarte, Kévin; Holdaas, Hallvard; Jardine, Alan G; Schmieder, Roland E; Fellström, Bengt; López-Andrés, Natalia; Rossignol, Patrick; Zannad, Faiez

Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids

利用机器学习模型和循环微核糖核酸提高终末期肾病血液透析患者的心血管风险预测能力

de Gonzalo-Calvo, David; Martínez-Camblor, Pablo; Bär, Christian; Duarte, Kevin; Girerd, Nicolas; Fellström, Bengt; Schmieder, Roland E; Jardine, Alan G; Massy, Ziad A; Holdaas, Hallvard; Rossignol, Patrick; Zannad, Faiez; Thum, Thomas

Arteriovenous fistula thrombosis is associated with increased all-cause and cardiovascular mortality in haemodialysis patients from the AURORA trial

AURORA试验表明,动静脉瘘血栓形成与血液透析患者的全因死亡率和心血管死亡率增加相关。

Girerd, Sophie; Girerd, Nicolas; Frimat, Luc; Holdaas, Hallvard; Jardine, Alan G; Schmieder, Roland E; Fellström, Bengt; Settembre, Nicla; Malikov, Sergei; Rossignol, Patrick; Zannad, Faiez

Prognostic utility of estimated albumin excretion rate in chronic kidney disease: results from the Study of Heart and Renal Protection

估算白蛋白排泄率在慢性肾脏病预后中的作用:来自心脏和肾脏保护研究的结果

Mafham, Marion M; Staplin, Natalie; Emberson, Jonathan; Haynes, Richard; Herrington, William; Reith, Christina; Wanner, Christoph; Walker, Robert; Cass, Alan; Levin, Adeera; Fellström, Bengt; Jiang, Lixin; Holdaas, Hallvard; Kasiske, Bertram; Wheeler, David C; Landray, Martin J; Baigent, Colin

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score

肾移植术后第一年补充帕立骨化醇不影响钙化倾向评分

Ussif, Amin; Pihlstrøm, Hege; Pasch, Andreas; Holdaas, Hallvard; Hartmann, Anders; Smerud, Knut; Åsberg, Anders

Immunosuppression Adherence in Stable Kidney Transplant Patients Converted From Immediate- to Prolonged-Release Tacrolimus in Clinical Practice: A Norwegian Study

挪威一项研究探讨了临床实践中,肾移植稳定期患者从速释他克莫司转换为缓释他克莫司后,免疫抑制剂治疗的依从性。

Abedini, Sadollah; Gøransson, Lasse; Cockburn, Elinor; Kilany, Suzanne; Holdaas, Hallvard

Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study

器官移植后皮肤癌风险的长期变化:一项基于人群的全国性队列研究

Rizvi, Syed Mohammad Husain; Aagnes, Bjarte; Holdaas, Hallvard; Gude, Einar; Boberg, Kristin Muri; Bjørtuft, Øystein; Helsing, Per; Leivestad, Torbjørn; Møller, Bjørn; Gjersvik, Petter

Should patients older than 65 years be offered a second kidney transplant?

65岁以上的患者是否应该接受第二次肾移植?

Heldal, Kristian; Hartmann, Anders; Lønning, Kjersti; Leivestad, Torbjørn; Reisæter, Anna V; Line, Pål-Dag; Holdaas, Hallvard; Midtvedt, Karsten